A carregar...

Fenretinide Prevents Lipid-induced Insulin Resistance by Blocking Ceramide Biosynthesis

Fenretinide is a synthetic retinoid that is being tested in clinical trials for the treatment of breast cancer and insulin resistance, but its mechanism of action has been elusive. Recent in vitro data indicate that fenretinide inhibits dihydroceramide desaturase, an enzyme involved in the biosynthe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bikman, Benjamin T., Guan, Yuguang, Shui, Guanghou, Siddique, M. Mobin, Holland, William L., Kim, Ji Yun, Fabriàs, Gemma, Wenk, Markus R., Summers, Scott A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366851/
https://ncbi.nlm.nih.gov/pubmed/22474281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.359950
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!